Home›Companies›OncoRock Therapeutics

OncoRock Therapeutics Inc.

Updated Oct 27, 2026·Latest SEC filing Oct 29, 2025·Suggest an edit

About OncoRock Therapeutics

OncoRock Therapeutics is a private company based in Little Rock, Arkansas, incorporated in 2025 in Delaware. It has reported $125,000 raised in one offering on Form D since October 2025.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 14, 2025Oct 29, 2025$125,000of $500K target3$41,667Securities on exercise, Simple Agreement for Future EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on OncoRock Therapeutics's Form D filed Oct 29, 2025.

AT
Alan Tackett
President and director
BK
Brian Koss
Executive officer and director

Sources

  1. SECOncoRock Therapeutics Inc. filing history